These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

288 related articles for article (PubMed ID: 38989406)

  • 1. Lactic acid: a narrative review of a promoter of the liver cancer microenvironment.
    Chen J; He G; Cai D; Giovannetti E; Inamura K; Liu S; Ma W
    J Gastrointest Oncol; 2024 Jun; 15(3):1282-1296. PubMed ID: 38989406
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tumor Microenvironment: Lactic Acid Promotes Tumor Development.
    Gao Y; Zhou H; Liu G; Wu J; Yuan Y; Shang A
    J Immunol Res; 2022; 2022():3119375. PubMed ID: 35733921
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Glucose Metabolism and Oxidative Stress in Hepatocellular Carcinoma: Role and Possible Implications in Novel Therapeutic Strategies.
    Mossenta M; Busato D; Dal Bo M; Toffoli G
    Cancers (Basel); 2020 Jun; 12(6):. PubMed ID: 32585931
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lactate-Lactylation Hands between Metabolic Reprogramming and Immunosuppression.
    Chen L; Huang L; Gu Y; Cang W; Sun P; Xiang Y
    Int J Mol Sci; 2022 Oct; 23(19):. PubMed ID: 36233246
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lactic Acid and an Acidic Tumor Microenvironment suppress Anticancer Immunity.
    Wang JX; Choi SYC; Niu X; Kang N; Xue H; Killam J; Wang Y
    Int J Mol Sci; 2020 Nov; 21(21):. PubMed ID: 33171818
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lactate from the tumor microenvironment - A key obstacle in NK cell-based immunotherapies.
    Jedlička M; Feglarová T; Janstová L; Hortová-Kohoutková M; Frič J
    Front Immunol; 2022; 13():932055. PubMed ID: 36330529
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Targeted lactate dehydrogenase genes silencing in probiotic lactic acid bacteria: A possible paradigm shift in colorectal cancer treatment?
    Macharia JM; Kaposztas Z; Varjas T; Budán F; Zand A; Bodnar I; Bence RL
    Biomed Pharmacother; 2023 Apr; 160():114371. PubMed ID: 36758316
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nanodrug regulates lactic acid metabolism to reprogram the immunosuppressive tumor microenvironment for enhanced cancer immunotherapy.
    Tian LR; Lin MZ; Zhong HH; Cai YJ; Li B; Xiao ZC; Shuai XT
    Biomater Sci; 2022 Jul; 10(14):3892-3900. PubMed ID: 35686599
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lactate in the Regulation of Tumor Microenvironment and Therapeutic Approaches.
    de la Cruz-López KG; Castro-Muñoz LJ; Reyes-Hernández DO; García-Carrancá A; Manzo-Merino J
    Front Oncol; 2019; 9():1143. PubMed ID: 31737570
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Functions of Key Enzymes of Glycolytic Metabolism in Tumor Microenvironment.
    Xu W; Weng J; Xu M; Zhou Q; Liu S; Hu Z; Ren N; Zhou C; Shen Y
    Cell Reprogram; 2023 Jun; 25(3):91-98. PubMed ID: 37172278
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lactate in the tumour microenvironment: From immune modulation to therapy.
    Wang ZH; Peng WB; Zhang P; Yang XP; Zhou Q
    EBioMedicine; 2021 Nov; 73():103627. PubMed ID: 34656878
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Beyond the Lactate Paradox: How Lactate and Acidity Impact T Cell Therapies against Cancer.
    Tu VY; Ayari A; O'Connor RS
    Antibodies (Basel); 2021 Jun; 10(3):. PubMed ID: 34203136
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Resveratrol reduces lactate production and modifies the ovarian cancer immune microenvironment.
    Chen J; Huang ST; Chen JG; He JH; Lin WM; Huang ZH; Ye HY; He SY
    Neoplasma; 2022 Sep; 69(5):1129-1137. PubMed ID: 36131607
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The oncogenic and clinical implications of lactate induced immunosuppression in the tumour microenvironment.
    Hayes C; Donohoe CL; Davern M; Donlon NE
    Cancer Lett; 2021 Mar; 500():75-86. PubMed ID: 33347908
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lactate in the tumor microenvironment: A rising star for targeted tumor therapy.
    Li Z; Wang Q; Huang X; Yang M; Zhou S; Li Z; Fang Z; Tang Y; Chen Q; Hou H; Li L; Fei F; Wang Q; Wu Y; Gong A
    Front Nutr; 2023; 10():1113739. PubMed ID: 36875841
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tumor-Derived Lactate Creates a Favorable Niche for Tumor
    Jin M; Cao W; Chen B; Xiong M; Cao G
    Front Cell Dev Biol; 2022; 10():808859. PubMed ID: 35646923
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lactate in the Tumor Microenvironment: An Essential Molecule in Cancer Progression and Treatment.
    Pérez-Tomás R; Pérez-Guillén I
    Cancers (Basel); 2020 Nov; 12(11):. PubMed ID: 33153193
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of glycolysis and lactate in the induction of tumor-associated macrophages immunosuppressive phenotype.
    Zhang Y; Zhang X; Meng Y; Xu X; Zuo D
    Int Immunopharmacol; 2022 Sep; 110():108994. PubMed ID: 35777265
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of infiltrating immune cells in tumor microenvironment on metastasis of hepatocellular carcinoma.
    Chen Y; Zhou Y; Yan Z; Tong P; Xia Q; He K
    Cell Oncol (Dordr); 2023 Dec; 46(6):1595-1604. PubMed ID: 37414962
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.